Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

about

Prognostic significance of sarcopenia in patients with hepatocellular carcinoma undergoing sorafenib therapy.

Item

http://www.wikidata.org/entity/Q41143489

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年論文

@yue

2017年論文

@zh-hant

2017年論文

@zh-hk

2017年論文

@zh-mo

2017年論文

@zh-tw

2017年论文

@wuu

2017年论文

@zh

2017年论文

@zh-cn

name

Prognostic significance of sar ...... undergoing sorafenib therapy.

@en

type

Item

label

Prognostic significance of sar ...... undergoing sorafenib therapy.

@en

prefLabel

Prognostic significance of sar ...... undergoing sorafenib therapy.

@en

P1476

Prognostic significance of sar ...... undergoing sorafenib therapy.

@en

P2093

Akihiro Nasu

http://www.w3.org/2001/XMLSchema#string

Azusa Sakamoto

http://www.w3.org/2001/XMLSchema#string

Hideyuki Komekado

http://www.w3.org/2001/XMLSchema#string

Hirayuki Enomoto

http://www.w3.org/2001/XMLSchema#string

Hiroki Nishikawa

http://www.w3.org/2001/XMLSchema#string

Hiroko Iijima

http://www.w3.org/2001/XMLSchema#string

Norihiro Nishijima

http://www.w3.org/2001/XMLSchema#string

Ryuichi Kita

http://www.w3.org/2001/XMLSchema#string

Shuhei Nishiguchi

http://www.w3.org/2001/XMLSchema#string

Takashi Nishimura

http://www.w3.org/2001/XMLSchema#string

P2860

Sorafenib: from literature to clinical practice

EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma

Sorafenib in advanced hepatocellular carcinoma

Sarcopenia in Cancer Patients

Sarcopenia predicts early dose-limiting toxicities and pharmacokinetics of sorafenib in patients with hepatocellular carcinoma

Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial

Hepatocellular carcinoma

Epidemiology of viral hepatitis and hepatocellular carcinoma

Sorafenib Therapy for BCLC Stage B/C Hepatocellular Carcinoma; Clinical Outcome and Safety in Aged Patients: A Multicenter Study in Japan

Treatment for hepatocellular carcinoma in Japan over the last three decades: Our experience and published work review

P304

1637-1647

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2017.6287

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-05-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28789390

http://www.w3.org/2001/XMLSchema#string

P932

5529937

http://www.w3.org/2001/XMLSchema#string